LIPOPROTEIN - ANVISA Registration 80416660026

Access comprehensive regulatory information for LIPOPROTEIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80416660026 and manufactured by SEBIA S.A.. The registration is held by SEBIA IMPORTAÇÕES COMERCIALIZAÇÃO E DISTRIBUIÇÃO DE APARELHOS E REATIVOS PARA DIAGNÓSTICO IN VITRO LTDA. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including DIASYS DIAGNOSTIC SYSTEMS GMBH, SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80416660026
Registration Details
ANVISA Registration Number: 80416660026
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

HYDRAGEL LIPO + Lp(a)
Risk Class II

Registration Details

80416660026

25351323808200943

08576331000186

Company Information

Dates and Status

Sep 14, 2009

VIGENTE

09/18/2025 19:00:01